Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1

Surgery
M G MutchT C Lairmore

Abstract

The usefulness of human pancreatic polypeptide (hPP) as a plasma marker for islet cell neoplasms is controversial. We sought to determine the relation between fasting plasma hPP levels and radiographically detectable pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1 (MEN 1). Fasting plasma hPP levels were measured prospectively in 202 individuals from 31 independent kindreds with MEN 1. Plasma levels greater than 3.0 times the normal age-specific values were defined as elevated. Patients with elevated plasma hPP levels were evaluated with computed tomographic scanning and magnetic resonance imaging, octreotide scanning, or selective angiography. Twenty-two patients had elevated fasting plasma hPP levels, and 20 of these patients were evaluated radiographically. Pancreatic lesions were detected in 19 patients. A group of eight patients with normal basal fasting plasma hPP levels were evaluated with computed tomography, magnetic resonance imaging, octreotide scanning, or selective angiography based on clinical presentation. One patient in this group had an imaging study that was positive for a pancreatic lesion. The presence of a markedly elevated fasting plasma hPP level in patients with MEN 1 is ...Continue Reading

References

Dec 2, 1978·Lancet·L OrciA Perrelet
Nov 1, 1989·The American Journal of Medicine·H FruchtR T Jensen
Dec 1, 1968·Endocrinology·J R KimmelR L Hazelwood
Oct 1, 1981·Archives of Surgery·J LonovicsJ C Thompson
Jun 1, 1993·Archives of Surgery·S WilkinsonJ J Shepherd

❮ Previous
Next ❯

Citations

Feb 5, 2002·Peptides·Cesare BordiSilvia Pizzi
Oct 3, 2002·Surgical Oncology·Matthew J Glascock, Sally E Carty
Aug 30, 2003·Surgical Oncology·Gerard M Doherty
Feb 15, 2000·Clinical Endocrinology·L B JohnstonM O Savage
Oct 23, 2002·Clinical Endocrinology·B MukhopadhyayS L Chew
May 19, 2000·Annals of Surgery·T C LairmoreG M Doherty
Mar 24, 2007·Endocrine Journal·Akihiro SakuraiKiyoshi Hashizume
Dec 9, 2008·Current Problems in Surgery·E Christopher Ellison, Jerome A Johnson
Feb 19, 2005·Journal of Surgical Oncology·Maria A KouvarakiDouglas B Evans
Oct 6, 2001·Frontiers in Neuroendocrinology·S W LambertsF R Nobels
Oct 29, 2005·Best Practice & Research. Clinical Gastroenterology·K Martin HoffmannRobert T Jensen
Sep 28, 2000·The American Journal of Gastroenterology·M A AndersonJ M Scheiman
Jul 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Paul J NeweyRajesh V Thakker
Dec 25, 2003·Srpski arhiv za celokupno lekarstvo·Radoje ColovićMilena Cosić-Micev
Sep 12, 2018·Journal of the Endocrine Society·Mark J C van TreijenGerlof D Valk
May 21, 2003·Journal of Internal Medicine·G M Doherty, N W Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.